Oxygenator thrombosis: worst case after development of an abnormal pressure gradient - incidence and pathway

The development of an abnormally high pressure gradient (APG) before the membrane oxygenator (MO) is a complication that occurs during some extracorporeal circulation (ECC) procedures. The present study deals with the incidence of an APG and discusses a probable causative pathway by comparing surface-coated and uncoated oxygenation systems. Five thousand six hundred and seventeen adult ECCs were carried out (2581 without and 3036 with surface coatings). The incidence of an APG, therefore, amounted to 0.03% in the group with coated systems and 4.3% in the uncoated group. In addition, an in vitro study demonstrated significantly reduced adhesion and activation of platelets and leucocytes when the surfaces of the MOs were coated with heparin or polypeptides. The advantages of coating surfaces of ECC devices possibly depend on the selective adsorption of particular plasma proteins. These will presumably form a biocompatible membrane on the surface, and minimize pathological deposit of fibrin, platelets and other blood cells, and, therefore, implicate the prevention of an oxygenator failure.

[1]  J. Schaadt.  Oxygenator thrombosis: an international phenomenon , 1999, Perfusion.

[2]  H P Wendel,et al.  Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  N. Weber,et al.  Increased adsorption of high molecular weight kininogen to heparin-coated artificial surfaces and correlation to hemocompatibility. , 1999, Immunopharmacology.

[4]  T. Åberg,et al.  Quality assurance in clinical perfusion. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  R. Colman,et al.  Three noncontiguous peptides comprise binding sites on high-molecular-weight kininogen to neutrophils. , 1998, American journal of physiology. Heart and circulatory physiology.

[6]  D. Birnbaum,et al.  Heparin-coated equipment reduces the risk of oxygenator failure. , 1998, The Annals of thoracic surgery.

[7]  L. Hsu.  Biocompatibility in cardiopulmonary bypass. , 1997, Journal of cardiothoracic and vascular anesthesia.

[8]  G Janvier,et al.  Extracorporeal circulation, hemocompatibility, and biomaterials. , 1996, The Annals of thoracic surgery.

[9]  R. Colman,et al.  Neutrophil adhesion on surfaces preadsorbed with high molecular weight kininogen under well-defined flow conditions. , 1996, Immunopharmacology.

[10]  M. Blombäck,et al.  Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass. , 1995, Journal of cardiothoracic and vascular anesthesia.

[11]  H. Wendel,et al.  Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  G. Gravlee,et al.  Heparin-coated cBypass circuits , 1994 .

[13]  L. Edmunds,et al.  Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.

[14]  L. Vroman.  The life of an artificial device in contact with blood: initial events and their effect on its final state. , 1988, Bulletin of the New York Academy of Medicine.

[15]  A. Schmaier,et al.  Initiation of Blood Coagulation at Artificial Surfaces , 1987, Annals of the New York Academy of Sciences.

[16]  A. Schmaier,et al.  Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit. , 1987, The American journal of physiology.

[17]  L. Vroman.  Possible relationships and interactions among events in clotting, platelet adhesion, immune surface reactions and granulocyte adhesion. , 1983, Journal of theoretical biology.

[18]  L. Vroman,et al.  PLATELETS ADHERE WHERE FLOW HAS LEFT FIBRINOGEN ON GLASS , 1983, Annals of the New York Academy of Sciences.

[19]  G. Gravlee.  Heparin-coated cardiopulmonary bypass circuits. , 1994, Journal of cardiothoracic and vascular anesthesia.

[20]  J. Brash,et al.  Identification of proteins absorbed to hemodialyser membranes from heparinized plasma. , 1993, Journal of biomaterials science. Polymer edition.

[21]  A. Schmaier,et al.  The effect of high molecular weight kininogen on surface-adsorbed fibrinogen. , 1984, Thrombosis research.